Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model

被引:7
|
作者
Phan, Thuy [1 ]
Nguyen, Vu H. [2 ]
Su, Rui [3 ]
Li, Yangchan [3 ]
Qing, Ying [3 ]
Qin, Hanjun [4 ]
Cho, Hyejin [4 ]
Jiang, Lei [5 ]
Wu, Xiwei [4 ]
Chen, Jianjun [3 ]
Fakih, Marwan [6 ]
Diamond, Don J. [2 ]
Goel, Ajay [7 ]
Melstrom, Laleh G. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Hematol, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Beckman Res Inst, Integrat Genom Core, Duarte, CA USA
[5] City Hope Natl Med Ctr, Dept Mol & Cellular Endocrinol, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA USA
[7] City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Monrovia, CA USA
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
colorectal cancer; FTO; FTO inhibitor; RNA-seq; signaling pathways; NUCLEAR-RNA; CELL-CYCLE; PHASE-II; EXPRESSION; N6-METHYLADENOSINE; PROGRESSION; DEMETHYLASE; MECHANISMS; BISANTRENE; RESISTANCE;
D O I
10.3389/fonc.2023.1087644
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionColorectal cancer (CRC) remains a significant cause of cancer related mortality. Fat mass and obesity-associated protein (FTO) is a m6A mRNA demethylase that plays an oncogenic role in various malignancies. In this study we evaluated the role of FTO in CRC tumorigenesis. MethodsCell proliferation assays were conducted in 6 CRC cell lines with the FTO inhibitor CS1 (50-3200 nM) (+/- 5-FU 5-80 mM) and after lentivirus mediated FTO knockdown. Cell cycle and apoptosis assays were conducted in HCT116 cells (24 h and 48 h, 290 nM CS1). Western blot and m6A dot plot assays were performed to assess CS1 inhibition of cell cycle proteins and FTO demethylase activity. Migration and invasion assays of shFTO cells and CS1 treated cells were performed. An in vivo heterotopic model of HCT116 cells treated with CS1 or with FTO knockdown cells was performed. RNA-seq was performed on shFTO cells to assess which molecular and metabolic pathways were impacted. RT-PCR was conducted on select genes down-regulated by FTO knockdown. ResultsWe found that the FTO inhibitor, CS1 suppressed CRC cell proliferation in 6 colorectal cancer cell lines and in the 5-Fluorouracil resistant cell line (HCT116-5FUR). CS1 induced cell cycle arrest in the G2/M phase by down regulation of CDC25C and promoted apoptosis of HCT116 cells. CS1 suppressed in vivo tumor growth in the HCT116 heterotopic model (p< 0.05). Lentivirus knockdown of FTO in HCT116 cells (shFTO) mitigated in vivo tumor proliferation and in vitro demethylase activity, cell growth, migration and invasion compared to shScr controls (p< 0.01). RNA-seq of shFTO cells compared to shScr demonstrated down-regulation of pathways related to oxidative phosphorylation, MYC and Akt/ mTOR signaling pathways. DiscussionFurther work exploring the targeted pathways will elucidate precise downstream mechanisms that can potentially translate these findings to clinical trials.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Interaction of two flavonols with fat mass and obesity-associated protein investigated by fluorescence quenching and molecular docking
    Wang, Zechun
    Wang, Ning
    Han, Xinxin
    Wang, Ruiyong
    Chang, Junbiao
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (13): : 3388 - 3397
  • [32] Computational study of potential inhibitors for fat mass and obesity-associated protein from seaweed and plant compounds
    Prabhakar, Lavanya
    Davis, Dicky John G.
    PEERJ, 2022, 10
  • [33] Investigating the Role of Fat Mass and Obesity-Associated (FTO) Single Nucleotide Polymorphisms and Methylation in Breast Cancer
    Hernandez-Caballero, Marta Elena
    Sierra-Ramirez, Jose Alfredo
    Pena-Gutierrez, Marlene De la
    Galindo-Ramirez, Fabian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [34] METABOLISM AND IMMUNE-RELATED TRANSCRIPTOMIC SIGNATURES IN A MOUSE MODEL OF OBESITY-ASSOCIATED COLORECTAL CANCER
    Glenny, Elaine M.
    Mirminachi, Babak
    McFarlane, Tori
    Hursting, Stephen D.
    Roper, Jatin
    GASTROENTEROLOGY, 2023, 164 (06) : S932 - S932
  • [35] Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach
    Prakash, Muthuraj
    Itoh, Yukihiro
    Fujiwara, Yoshie
    Takahashi, Yukari
    Takada, Yuri
    Mellini, Paolo
    Elboray, Elghareeb E.
    Terao, Mitsuhiro
    Yamashita, Yasunobu
    Yamamoto, Chika
    Yamaguchi, Takao
    Kotoku, Masayuki
    Kitao, Yuki
    Singh, Ritesh
    Roy, Rohini
    Obika, Satoshi
    Oba, Makoto
    Wang, Dan Ohtan
    Suzuki, Takayoshi
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 15810 - 15824
  • [36] Cerebroprotective Role Of M6A Demethylase Fat Mass And Obesity-associated Protein After Experimental Stroke
    Vemuganti, Raghu
    Chokkalla, Anil K.
    Jeong, Soomin
    Mehta, Suresh L.
    Morris-Blanco, Kahlilia
    Bathula, Saivenkateshkomal
    Qureshi, Simran
    STROKE, 2023, 54
  • [37] Fat mass and obesity-associated protein regulates RNA methylation associated with spatial cognitive dysfunction after chronic cerebral hypoperfusion
    Wang, Yanqing
    Wu, Zimei
    He, Yuyang
    Zeng, Xiaoying
    Gu, Zijuan
    Zhou, Xianxi
    Si, Wenwen
    Chen, Dongfeng
    NEUROPEPTIDES, 2024, 105
  • [38] Tirzepatide mitigates obesity-associated metabolic dysregulation and tumor progression in a mouse model of triple-negative breast cancer
    Glenny, Elaine M.
    Ho, Alyssa N.
    Kiesel, Violet A.
    Chen, Fangxin
    Gates, Claire E.
    Paules, Evan M.
    Xu, Ruihan
    Holt, C. Alex
    Coleman, Michael F.
    Hursting, Stephen D.
    CANCER RESEARCH, 2024, 84 (06)
  • [39] N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells
    Mo, Wentao
    Chen, Ziqi
    Zhang, Xiaozhe
    Dai, Gang
    Ma, Dongwei
    Pan, Jiajie
    Zhang, Xinxia
    Wu, Guifu
    Fan, Wendong
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (05) : 644 - 658
  • [40] Off-Target Inhibition of Human Dihydroorotate Dehydrogenase (hDHODH) Highlights Challenges in the Development of Fat Mass and Obesity-Associated Protein (FTO) Inhibitors
    Tarullo, Marco
    Fernandez Rodriguez, Guillermo
    Iaiza, Alessia
    Venezia, Sara
    Macone, Alberto
    Incocciati, Alessio
    Masciarelli, Silvia
    Marchioni, Marcella
    Giorgis, Marta
    Lolli, Marco Lucio
    Fornaseri, Federico
    Proietti, Ludovica
    Grebien, Florian
    Rosignoli, Serena
    Paiardini, Alessandro
    Rotili, Dante
    Mai, Antonello
    Bochenkova, Elena
    Caflisch, Amedeo
    Fazi, Francesco
    Fatica, Alessandro
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (12) : 4096 - 4111